NHS Patient Safety Technology Provider Patientrack Becomes Alcidion

Alcidion LtdA technology company that has helped NHS hospitals in England and Scotland to quickly identify and respond to their sickest patients, will now be known as Alcidion. Patientrack, which is known for providing technology for electronic patient observations and early warnings of patient deterioration to the NHS, first announced it had been acquired by Alcidion Group Limited in 2018.

The company's product - also called Patientrack - will still be available to NHS hospitals, which have recordedsignificant gains in patient safety by using the technology - including reductions in cardiac arrests, mortality, lengths of stay, and admissions to intensive care. Hospitals have also innovated with the Patientrack technology to tackledeadly conditions, including acute kidney injury and sepsis.

Whilst the Patientrack product will remain fully supported with the same dedicated UK team, the company has now been formally rebranded as Alcidion, to reflect its wider offering of cutting edge technology to the NHS, designed to transform healthcare.

Donald Kennedy, UK general manger, Alcidion, said: “We are building on a remarkable legacy of collaboration with the NHS that has delivered a big impact on patient safety.

"As Alcidion, we have the ability to take this to the next level, and to offer the NHS a much wider set of digital tools. These have been designed to not only support the next generation of patient safety, but to streamline patient journeys, increase operational efficiency, inform clinical decision making and help hospitals to understand their data.

"We are already doing all of this with early NHS pioneers, and so it is only fitting that we adopt our new identity that reflects our even more compelling offer to the NHS."

Dartford and Gravesham NHS Trust became the first UK organisation to procure the full Alcidion product suite in a five-year partnership announced earlier in 2019. The trust is deploying ahealth technology platformthat will transform patient safety and clinical efficiency for its hospitals and its local healthcare system partners and will help the trust realise its mission to become a self-made digital exemplar.

Alcidion provides solutions spanning predictive analytics, patient flow, clinical messaging, integration support, and clinical decision making. The Patientrack product will continue to perform its electronic observations, patient assessments and early warning role, as part of an integrated offering with other Alcidion products. This includes the Miya platform, which provides decision intelligence software that consolidates real-time data from disparate healthcare IT systems and pushes decision intelligence and guidance to users via mobile devices.

The Miya platform is cloud based with analytics tools to help professionals manage clinical workflows and reduce avoidable injury. It provides logistics tools to give valuable time back to the care team.

Smartpage, the company's clinical messaging system is used in hospitals to improve communication and safety in the clinical environment.

Kate Quirke, managing director of Alcidion, said: "This is about transforming healthcare together, by empowering doctors and nurses to deliver the best possible outcomes for their patients. We are already working with the NHS to use technology in a way that delivers insights to clinicians so they can prevent and intervene.

"Healthcare professionals need to understand how their patients are progressing and need to have information about their current status and potential risk. Alcidion has rapidly developed in the last 12 months in meeting these challenges, with acquisitions allowing us to grow into a leading informatics company helping healthcare providers throughout the world.

"People in the NHS have come to know Patientrack as an important innovator in the patient safety arena, and we now look forward to developing that innovation to a growing number of areas, as we continue to partner with one of the most respected health institutions in the world to deliver the best for its patients."

About Alcidion Ltd

Alcidion Ltd (ASX:ALC) has a simple purpose, that is, to make healthcare better with smart, intuitive solutions that meet the needs of hospital and allied healthcare, worldwide. Alcidion incorporates three healthcare software companies previously known as Alcidion Corporation, Patientrack and Smartpage, and MKM Health, an IT solutions and services provider. Each company brings a complementary set of products and skills that create a unique offering in the global healthcare market; solutions that support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient outcomes. With over 25 years of combined healthcare experience, the Alcidion Group of companies brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...